Amid COVID-19 crisis, flu shot makers see record US production

Washington (AFP) - Global influenza vaccine makers have produced a record number of doses for the coming flu season, as authorities try to ease the burden on hospitals ahead of an expected COVID-19 resurgence.In the US, pharmaceutical companies plan to make around 196 million doses to serve the population of 330 million, according to the Centers for Disease Control and Prevention (CDC). That is up from 175 million last year, an 11 percent increase. Major pharmacy chain CVS, which administers flu vaccines without prescription, is ordering 18 million doses, double the amount in 2019.Vaccine make...

Read More